49 Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$297K Buy
3,431
+296
+9% +$28.4K 0.02% 149
2025
Q4
$301K Sell
3,135
-134
-4% -$13K 0.02% 151
2025
Q3
$311K Sell
3,269
-97
-3% -$8.92K 0.03% 146
2025
Q2
$293K Buy
3,366
+47
+1% +$3.99K 0.03% 137
2025
Q1
$298K Buy
3,319
+43
+1% +$3.85K 0.04% 138
2024
Q4
$262K Sell
3,276
-719
-18% -$62.2K 0.04% 136
2024
Q3
$360K Sell
3,995
-1,215
-23% -$102K 0.06% 106
2024
Q2
$402K Sell
5,210
-99
-2% -$8.12K 0.08% 94
2024
Q1
$462K Buy
5,309
+160
+3% +$13.7K 0.1% 59
2023
Q4
$424K Buy
+5,149
New +$392K 0.11% 60

Other funds holding MDT

49 Wealth Management's MDT Position: Q1 2026 in Review

49 Wealth Management increased its Medtronic (MDT) stake by 9.4% in Q1 2026, buying an estimated $28.4K and bringing the position to 3,431 shares worth $297K. The position accounts for 0.02% of the portfolio, ranked #149.

49 Wealth Management first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $462K in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • 49 Wealth Management held 3,431 shares of Medtronic worth $297K as of Q1 2026.
  • 49 Wealth Management bought 296 Medtronic shares in Q1 2026, an estimated $28.4K.
  • Medtronic made up 0.02% of 49 Wealth Management's portfolio in Q1 2026, its #149 holding.
  • 49 Wealth Management first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • 49 Wealth Management's Medtronic position peaked at $462K in Q1 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on 49 Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.